Suppr超能文献

西布曲明和利莫那班对经训练可区分22小时和2小时食物剥夺的大鼠的影响。

Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation.

作者信息

Jewett David C, Hahn Thomas W, Smith Travis R, Fiksdal Britta L, Wiebelhaus Jason M, Dunbar Andrew R, Filtz Catherine R, Novinska Noah L, Levine Allen S

机构信息

Department of Psychology, University of Wisconsin-Eau Claire, Eau Claire, WI, USA.

出版信息

Psychopharmacology (Berl). 2009 Apr;203(2):453-9. doi: 10.1007/s00213-008-1350-1. Epub 2008 Oct 15.

Abstract

OBJECTIVE

The objective of the study was to evaluate whether sibutramine and rimonabant, drugs that decrease food intake in human and non-human animals, affect the discriminative stimulus effects associated with acute food deprivation ("hunger").

MATERIALS AND METHODS

Rats were trained to discriminate between 22- and 2-h food deprivation in a two-lever choice procedure. After rats acquired the discrimination, subjects were food-restricted for 22 h and administered with sibutramine (0.32-10 mg/kg, p.o.) or rimonabant (0.32-10 mg/kg, s.c.) before a generalization test session.

RESULTS

Sibutramine (3.2 mg/kg) produced significant decreases in 22-h deprivation-appropriate responding, response rates (resulting in lever pressing rates similar to those following 2-h food deprivation), and food intake measured 1 h after the generalization test. A larger sibutramine dose eliminated responding and significantly reduced food intake. Rimonabant did not alter the discriminative stimulus effects of 22-h food deprivation, but rimonabant did significantly reduce both response rates and food intake.

CONCLUSION

Sibutramine appears to decrease food intake by reducing hunger sensations associated with food deprivation. In contrast, rimonabant does not alter the discrimination of acute food deprivation. The use of food-deprivation discrimination techniques may be useful in identifying the role of specific neuroactive compounds in eating stimulated by a sense of hunger and may aid in medication development for more effective treatments for obesity and other eating-related conditions.

摘要

目的

本研究的目的是评估西布曲明和利莫那班这两种能减少人类和非人类动物食物摄入量的药物,是否会影响与急性食物剥夺(“饥饿”)相关的辨别刺激效应。

材料与方法

在双杠杆选择程序中训练大鼠区分22小时和2小时的食物剥夺情况。大鼠获得辨别能力后,对其进行22小时的食物限制,并在泛化测试前给予西布曲明(0.32 - 10毫克/千克,口服)或利莫那班(0.32 - 10毫克/千克,皮下注射)。

结果

西布曲明(3.2毫克/千克)使22小时剥夺相关反应显著减少,反应率(导致杠杆按压率与2小时食物剥夺后的相似)以及泛化测试后1小时测量的食物摄入量均显著降低。更高剂量的西布曲明消除了反应并显著降低了食物摄入量。利莫那班未改变22小时食物剥夺的辨别刺激效应,但显著降低了反应率和食物摄入量。

结论

西布曲明似乎通过减少与食物剥夺相关的饥饿感来降低食物摄入量。相比之下,利莫那班不会改变对急性食物剥夺的辨别。使用食物剥夺辨别技术可能有助于确定特定神经活性化合物在饥饿感刺激进食中的作用,并可能有助于开发更有效的肥胖及其他饮食相关病症治疗药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验